Explore Precision BioSciences' advances in gene therapy for hepatitis B, strong funding till 2028, and what it means for ...

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 ...

Accomplished biopharma executive with deep experience leading the development of complex biologics and gene therapies at ...

Five studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition reveal new ...

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research ...

"You could really, in a very fundamental sense, talk about redrawing the border around a brain," Hodak says, "possibly to ...

Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

A handful of people with HIV have been cured after receiving HIV-resistant stem cells – but a man who received non-resistant ...

Mr. Kim will participate in a panel discussion titled "The Future for Rare Heart Disease" alongside Linda Marban of Capricor. The panel will take place on Thursday, December 11, 2025, from 2:15 to ...

A German man remains in remission from HIV an incredible six years after he received a stem cell transplant to treat an ...

A congressman bought shares of a small cap company recently. Here's a look at the stock and why it's drawing attention.

INDIANAPOLIS — Indiana University and pharmaceutical giant Eli Lilly have made official a five-year collaboration in which ...